SCIENTURE HOLDINGS, INC. Operating Lease, Expense
SCIENTURE HOLDINGS, INC. (SCNX) reported Operating Lease, Expense of $20.93 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-06-26
- SCIENTURE HOLDINGS, INC. operating lease, expense for the quarter ending 2024-03-31 was $20.93K, a 74.17% decline year-over-year.
- SCIENTURE HOLDINGS, INC. operating lease, expense for the quarter ending 2023-03-31 was $81.02K.
- SCIENTURE HOLDINGS, INC. operating lease, expense for the quarter ending 2020-12-31 was $32.51K.
- SCIENTURE HOLDINGS, INC. operating lease, expense for fiscal 2020 was $97.03K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|
| 2024-03-31 | $20.93K 10-Q · filed 2024-06-26 | ||
| 2023-03-31 | $81.02K 10-Q · filed 2024-06-26 | ||
| 2020-12-31 | $32.51K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $97.03K 10-K · filed 2021-03-29 | |
| 2020-09-30 | $64.52K 10-Q · filed 2020-10-26 | ||
| 2019-09-30 | $55.10K 10-Q · filed 2020-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |